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Abstract: Neutrophils possess a very short life-
span, dying by apoptosis. HL-60 cells undergo
apoptosis after neutrophil differentiation with di-
methyl sulfoxide (DMSO). We have found that the
onset of apoptosis in neutrophil-differentiating
HL-60 cells correlates with the achievement of an
apoptosis-related gene expression pattern similar
to that of peripheral blood mature neutrophils.
Using reverse transcriptase-polymerase chain reac-
tion, cloning, and sequencing techniques, we have
found that HL-60 cells express bak, bik, bax, bad,
bcl-2, bcl-xL, bcl-w, bfl-1, fas, and caspases 1–4
and 7–10. After DMSO treatment, bak, bcl-w,
bfl-1, fas, and caspases 1 and 9 were up-regulated,
whereas bik, bcl-2, and caspases 2, 3, and 10 were
down-regulated at different degrees, achieving
mRNA expression levels that correlated with those
detected in peripheral blood neutrophils. Caspase-2
mRNA and protein expression was drastically re-
duced after HL-60 cell differentiation, being ab-
sent in both HL-60-differentiated neutrophils and
mature neutrophils, whereas caspase-3 and -10
mRNA and protein expression were diminished
upon HL-60 cell differentiation until achieving the
respective levels found in mature neutrophils. Bak
and bfl-1 mRNA levels were largely increased
during DMSO-induced differentiation of HL-60
cells, and these genes were the bcl-2 family mem-
bers that were expressed most abundantly in ma-
ture neutrophils. Bcl-2 overexpression or caspase
inhibition prevented differentiation-induced apop-
tosis in HL-60 cells, but not their differentiation
capability. Neutrophil spontaneous apoptosis was
also blocked by the caspase inhibitor z-Asp-2,6-
dichlorobenzoyloxymethylketone. Peripheral blood
neutrophils expressed bak, bad, bcl-w, bfl-1, fas,
and caspases 1, 3, 4, and 7–10, but hardly ex-
pressed bcl-2, bcl-xL, bik, bax, and caspase-2.
These results suggest that the above gene expres-
sion changes in neutrophil-differentiating HL-60
cells may play a role in the acquisition of the
neutrophil apoptotic features. J. Leukoc. Biol. 67:
712–724; 2000.
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INTRODUCTION
Neutrophils play a major role in the host defenses against the
invasion of microorganisms and in acute inflammation and have
been implicated in the pathogenesis of a number of human
diseases [1]. About ten million new neutrophils are produced
and released into the bloodstream from the bone marrow every
minute in the average adult [2]. However, the number of
circulating neutrophils remains constant, indicating that an
equivalent number of neutrophils must be deleted continuously
to maintain a proper balance of neutrophils in peripheral blood.
Neutrophils enter the bloodstream and tissues as terminally
differentiated cells, which are unable to self-renew and have
the shortest half-life of all circulating leukocytes. After leaving
the bone marrow, neutrophils are programmed to die within
about 24 h as a result of constitutive and spontaneous apoptosis
[3–5], a controlled biological process leading to the physiologi-
cal death of the cell, and characterized by cell shrinkage,
chromatin condensation, and internucleosomal DNA degrada-
tion, widely considered to be a biochemical hallmark of
apoptosis [6].
Accumulating evidence indicates that the Fas (APO-1;
CD95)/Fas ligand (FasL) system represents an important cellu-
lar pathway responsible for the induction of apoptosis in a wide
variety of tissues. Fas is a widely expressed 45-kDa type I
membrane protein member of the tumor necrosis factor (TNF)/
nerve growth factor receptor superfamily, which mediates
apoptosis [7–11]. Fas is activated to induce apoptosis after
interaction with agonistic anti-Fas IgM antibodies or with its
natural ligand FasL, a 40-kDa type II protein member of the
TNF family [9, 10, 12, 13]. In contrast to Fas, constitutive
expression of FasL is relatively restricted in its tissue distribu-
tion [9–11], but it can be induced under different experimental
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conditions in several cell types [14–17]. After programmed cell
death is triggered, the process of apoptosis is mainly regulated
by different members of two growing gene families, namely
Bcl-2-related genes and caspases, as well as Apaf-1. Since the
initial identification of the bcl-2 gene as a proto-oncogene
deregulated in t(14;18)-bearing B cell lymphomas [18], several
homologous proteins have subsequently been identified that
comprise the growing Bcl-2 protein family. Some members of
this Bcl-2 protein family inhibit apoptosis (Bcl-2, Bcl-xL, Bcl-w,
Bfl-1) and others promote apoptosis (Bax, Bak, Bik, Bad,
Bcl-xs) [19–22]. The so-called caspase family includes a
growing family of at least 14 cysteine proteases showing
homology with the mammalian protein interleukin-1b-convert-
ing enzyme (ICE) and exerting an effector function in pro-
grammed cell death [23, 24]. The name caspase for these
ICE-like proteases was selected to indicate two catalytic
properties of these enzymes: the ‘‘c’’ denoting a cysteine
protease, and the ‘‘aspase’’ referring to their ability to cleave
after an aspartic residue [25].
The human promyelocytic HL-60 cell line has been widely
used as a cell culture model of human neutrophils [26–28].
HL-60 cells can be induced to differentiate toward cells sharing
several functional features of mature neutrophils and, like
neutrophils, die through spontaneous apoptosis after acquiring
the biochemical and functional properties of mature neutro-
phils [28, 29]. Thus, HL-60 cells are a good model to study the
apoptotic processes involved in neutrophil programmed cell
death. A hallmark of neutrophil physiology is their rapid and
spontaneous programming for cell death [4, 30]. It is well
known that apoptosis is the major mechanism for limiting the
neutrophil content in vivo, and seems to play an important role
in the clearance of neutrophils from inflamed tissues by tissue
macrophages, which is critical in the limitation of inflammatory
tissue injury and in the subsequent resolution of inflammation
[3, 30, 31]. However, transgenic mice that expressed bcl-2 in
mature neutrophils showed that Bcl-2 blocked apoptosis of
neutrophils, but not their engulfment by macrophages [32]. This
suggests that the mechanism that triggers phagocytosis of aging
neutrophils operates independently of the process of apoptosis
regulated by Bcl-2, and that aging neutrophils exhibit cell-
surface changes that allow them to be recognized and engulfed
by macrophages independently of the apoptotic phases regu-
lated by Bcl-2. Most inflammatory mediators and neutrophil
activators [such as granulocyte-macrophage colony-stimulating
factor (GM-CSF), granulocyte-CSF (G-CSF), and lipopolysaccha-
ride (LPS)] prolong the functional lifespan of neutrophils
through modulation of apoptosis [30, 31, 33–35]. However, the
molecular mechanisms and constituents controlling neutrophil
apoptosis remain largely unknown. The Fas/FasL system seems
to represent a key mechanism controlling the rapid spontaneous
turnover of neutrophils after their release from the bone marrow.
Mature neutrophils are highly susceptible to Fas-induced death
[36, 37] and co-express constitutively Fas and FasL in their cell
membrane [37, 38]. Spontaneous neutrophil death in vitro was
partially suppressed by Fas-Ig fusion protein or antagonistic
anti-Fas IgG1 (ZB4 monoclonal antibody) [37]. This partial, but
not complete, inhibition of neutrophil death indicates that the
Fas/FasL pathway is an important, but not exclusive, mecha-
nism involved in the regulation of spontaneous neutrophil
apoptosis. This suggests that redundant mechanisms exist to
ensure neutrophil apoptosis. Mature neutrophils are essentially
absent for bcl-2 expression [36]. HL-60 cells express bcl-2, but
induction of HL-60 differentiation toward the granulocytic
pathway is accompanied by a marked decrease in bcl-2 mRNA
and protein levels [39–41]. In this report, we examine the
expression of a wide number of Bcl-2 and caspase family
members in mature neutrophils and during differentiation of
HL-60 cells toward the neutrophil lineage. We show that mature
neutrophils and HL-60 cells differentiated toward neutrophils
(HL-60 neutrophils) with dimethyl sulfoxide (DMSO) share
characteristic and very similar patterns of expression of genes
involved in the initiation, regulation, and execution of apopto-
sis. Here, we show a number of marked changes in apoptosis-
related genes during HL-60 cell differentiation toward the
neutrophil lineage, which correlate with the appearance of the
neutrophil apoptotic features. The importance of both bcl-2 and
caspase gene families in the onset of mature neutrophil or
HL-60 neutrophil apoptosis is highlighted by its prevention by
caspase inhibition as well as by Bcl-2 overexpression. The
similar constitutive and acquired apoptosis-related gene expres-
sion patterns shown by mature neutrophils and HL-60 neutro-
phils, respectively, seem to account for the short lifespan of
both physiological peripheral blood neutrophils and cell cul-
ture model HL-60 neutrophils.
MATERIALS AND METHODS
Chemicals and reagents
RPMI 1640, fetal calf serum, antibiotics, L-glutamine, and TRIZOL reagent
were purchased from GIBCO BRL (Grand Island, NY). Nitroblue tetrazolium
(NBT) was from Sigma Chemical (St. Louis, MO). The anti-CD11b monoclonal
antibody Bear 1 [42] was generously provided by Dr. J. E. De Vries (Unicet,
Lyon, France). The anti-CD71 monoclonal antibody [43] and the P3X63
myeloma culture supernatant, used as a negative control, were kindly provided
by Dr. F. Sa´nchez-Madrid (Hospital de la Princesa, Madrid, Spain). Mouse
monoclonal IgG1 anti-caspase-2 antibody, and rabbit polyclonal anti-caspase-3
and anti-caspase-10 antibodies were from PharMingen (San Diego, CA).
Fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse immunoglobu-
lin was from Dakopatts (Glostrup, Denmark). Ficoll-Paque was from Pharmacia
LKB Biotechnology (Uppsala, Sweden). M-MLV reverse transcriptase was from
Promega (Madison, WI). Taq DNA polymerase was from ECOGEN (Barcelona,
Spain). DMSO was from Merck (Darmstadt, Germany). The caspase inhibitor
z-Asp-2,6-dichlorobenzoyloxymethylketone was from Alexis (La¨ufelfingen,
Switzerland). All other chemicals were from Merck or Sigma.
Cells and culture conditions
The human leukemic cell lines HL-60 (acute myeloid leukemia) and NB4
(promyelocytic leukemia) were grown in RPMI 1640 culture medium supple-
mented with 10% (vol/vol) heat-inactivated fetal calf serum, 2 mM L-glutamine,
100 units/mL penicillin, and 24 µg/mL gentamicin. HL-60 cells transfected
with the SFFV-Neo expression vector containing the human bcl-2 open reading
frame (HL-60-Bcl-2) and with empty SFFV-Neo plasmid (HL-60-Neo), kindly
provided by Dr. J. L. Fernandez-Luna and Dr. A. Benito [41], were grown as
above in RPMI 1640 cell culture medium containing 10% (vol/vol) heat-
inactivated fetal calf serum and 1 mg/mL G418. Cells were incubated at 37°C
in a humidified atmosphere of air/CO2 (19/1). Neutrophil differentiation of
HL-60 cells was induced by treatment with 1.3% (vol/vol) DMSO for the days
indicated in the respective figures. The caspase inhibitor z-Asp-2,6-
dichlorobenzoyloxymethylketone (50 µM) was added 1 h before DMSO addition
and every 48 h during DMSO incubation of HL-60 cells.
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Human neutrophils were obtained from fresh heparinized peripheral blood
obtained from healthy volunteers. Neutrophils were isolated by dextran
sedimentation and centrifugation on Ficoll-Paque (Pharmacia LKB Biotechnol-
ogy), followed by hypotonic lysis of residual erythrocytes [44]. The final cell
preparation contained more than 99% neutrophils, as assessed by May-
Gru¨nwald-Giemsa staining. Cell viability was evaluated by trypan blue dye
exclusion and was always higher than 99%.
Morphological assessment
of neutrophil apoptosis
About 2 3 105 neutrophils in 200 µL were cytospun at 1,000 rpm for 2 min
(cytospin 3, Shandon Scientific, Cheshire, UK). Cells were then air-dried
briefly and May-Gru¨nwald-Giemsa-stained with a commercial kit from Merck.
Apoptotic cells were identified by characteristic chromatin condensation and
cytoplasmic vacuolization.
Visualization of DNA fragmentation
by agarose gels
To analyze apoptosis, we isolated fragmented DNA as described [28, 45].
Briefly, 2 3 106 cells were washed with phosphate-buffered saline (PBS) and
then lysed with 200 µL hypotonic detergent buffer (10 mM Tris-HCl, pH 7.5, 1
mM EDTA, and 0.2% Triton X-100) for 30 min at 4°C. Nuclear and subcellular
organelles were removed by centrifugation in a microfuge for 20 min, and the
supernatant, containing the DNA released into the cytosol due to DNA
fragmentation was incubated with RNase A (300 µg/mL) for 45 min at 37°C,
and then with 200 µg/mL proteinase K in the presence of 0.5% (w/v) SDS for an
additional 45 min at 37°C. Then the DNA was extracted, precipitated, and
analyzed by electrophoresis on 1% (w/v) agarose gels as described previously
[28, 45]. DNA was visualized after electrophoresis by ethidium bromide
staining.
Analysis of DNA fragmentation by flow cytometry
Neutrophils (5 3 105) were centrifuged and fixed overnight in 70% ethanol at
4°C. Then, cells were washed three times with PBS and incubated for 1 h with 1
mg/mL RNase A and 20 µg/mL propidium iodide at room temperature. Cells
were then analyzed for cell cycle with a Becton Dickinson (San Jose, CA)
FACScan flow cytometer. The induction of apoptosis was monitored as the
appearance of a sub-G1/G0 peak (hypodiploidy) in cell cycle analysis.
Analysis of cell-surface antigens by
immunofluorescence flow cytometry
The cell-surface expression of CD11b and CD71 antigens was analyzed by
immunofluorescence flow cytometry analysis in a FACScan flow cytometer
(Becton Dickinson) as previously described [28, 46]. Fluorescence data were
collected in log scale. Results were shown as percentages of positive cells for
each antigen; cells incubated with P3X63 myeloma culture supernatant were
used as a negative control.
NBT reduction
Respiratory burst activity was measured by NBT reduction as described
previously [28]. Cells were stimulated with 50 ng/mL phorbol myristate acetate
(PMA) for 15 min at 37°C in the presence of 0.1% (w/v) NBT followed by
centrifugation, washing (70% methanol), and addition of 2 M KOH to lyse the
cells, and DMSO to dissolve the formazan blue pellet. NBT reduction was
quantified by the difference in the absorbencies at l620 and l450 nm as
described previously [28].
Reverse transcriptase-polymerase
chain reaction (RT-PCR)
Total RNA was extracted from human neutrophils and cell lines according to
the protocol of Chomczynski and Sacchi [47] or using TRIZOL reagent (GIBCO
BRL) following the manufacturer’s instructions. RNA preparations were
carefully checked by gel electrophoresis and found to be free of DNA
contamination. For the RT reaction, total RNA (3 µg) was primed with oligo(dT)
and reverse-transcribed into cDNA with 30 units of M-MLV reverse transcrip-
tase from Promega, according to manufacturer’s instructions, in a final volume
of 20 µL. The mixture was incubated at 37°C for 2 h. The generated cDNA was
used for the semiquantitative RT-PCR analysis to assess mRNA expression as
previously described [48], and the b-actin gene was used as an internal control.
A 25-µL PCR mixture contained 1 µL of the RT reaction, 10 pmol of each
primer, each dNTP (0.2 mM), 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM
MgCl2, and 2.5 units of EcoTaq DNA polymerase derived from Thermus
aquaticus. PCR reactions were performed in a GeneAmp PCR System model
9600 (Perkin Elmer, Norwalk, CT). The primers used are listed below, where
the nucleotide numbers indicate the primer location in the corresponding
sequences of human origin obtained from the GenBank/EMBL database:
b-actin (accession number: X00351)
(forward; nt 936–955)58-CTGTCTGGCGGCACCACCAT-3’
(reverse; nt 1170–1189)58-GCAACTAAGTCATAGTCCGC-38
bcl-w (accession number: U59747)
(forward; nt 34–53)58-GCTCTGGTGGCAGACTTTGT-38
(reverse; nt 377–396)58-ATCCACTCCTGCACTTGTCC-38
bcl-2 (accession number: M13994)
(forward; nt 1799–1823)58-AGATGTCCAGCCAGCTGCACCTGAC-38
(reverse; nt 2139–2165)58-AGATAGGCACCCAGGGTGATGCAAGCT-38
bax (accession number: L22473)
(forward; nt 172–195)58-AAGCTGAGCGAGTGTCTCAAGCGC-38
(reverse; nt 516–537)58-TCCCGCCACAAAGATGGTCACG-38
bik (accession number: U34584)
(forward; nt 68–89)58-ACCCTCCTGTATGAGCAGCTCC-38
(reverse; nt 295–318)58-TCAGTCTGGTCGTAGATGAAAGCC-38
bfl-1 (accession number: U27467)
(forward; nt 65–86)58-AGGCTGGCTCAGGACTCTCTGC-38
(reverse; nt 544–568)58-TTCTGGTCAACAGTATTGCTTCAGG-38
bak (accession number: X84213)
(forward; nt 23–47)58-TCCAGATGCCGGGAATGCACTGACG-38
(reverse; nt 1191–1214)58-TGGTGGGAATGGGCTCTCACAAGG-38
bcl-xL (accession number: Z23115)
(forward; nt 381–402)58-ATGGCAGCAGTAAAGCAAGCGC-38
(reverse; nt 903–922)58-TTCTCCTGGTGGCAATGGCG-38
bad (accession number: AF031523)
(forward; nt 26–45)58-CGAGTGAGCAGGAAGACTCC-38
(reverse; nt 324–341)58-CTGTGCTGCCCAGAGGTT-38
caspase-1 (ICEb) (accession number: U13700)
(forward; nt 6–25)58-CGACAAGGTCCTGAAGGAGA-38
(reverse; nt 1062–1081)58-CATCTGGCTGCTCAAATGAA-38
caspase-2 (ICH-1) (accession number: U13021)
(forward; nt 773–797)58-CAGTTACCTGCACACCGAGTCACGG-38
(reverse; nt 1135–1158)58-AGCCGCATATCATGTCTGAGCGCG-38
caspase-3 (CPP32, yama, apopain) (accession number: U26943)
(forward; nt 340–361)58-TTTGTTTGTGTGCTTCTGAGCC-38
(reverse; nt 720–739)58-ATTCTGTTGCCACCTTTCGG-38
caspase-4 (TX, ICH-2, ICErelII) (accession number: U28014)
(forward; nt 199–221)58-TCGGGTCATGGCAGACTCTATGC-38
(reverse; nt 679–700)58-ATGCACAGTTCCGCAGATTCCC-38
caspase-5 (ICErelIII, TY) (accession number: U28015)
(forward; nt 120–143)58-TCCAGACCCTAGTACCTAATACGG-38
(reverse; nt 664–683)58-CGTCAACCACAGTGTAGCCC-38
caspase-6 (Mch2) (accession number: U20536)
(forward; nt 512–536)58-GAGACAAGTGTCACAGCCTGGTTGG-38
(reverse; nt 1246–1264)58-TGCAATGGCGCAATGCTCG-38
caspase-7 (Mch3, ICE-LAP3, CMH-1) (accession number: U37448)
(forward; nt 179–198)58-CGATCCATCAAGACCACCCG-38
(reverse; nt 692–715)58-GGAATAGGCGAAGAGGAAGTCAGC-38
caspase-8 (MACHalpha, FLICE, Mch5) (accession number: X98172)
(forward; nt 1064–1087)58-GGGACAGGAATGGAACACACTTGG-38
(reverse; nt 1597–1621)58-TCAGGATGGTGAGAATATCATCGCC-38
caspase-9 (ICE-LAP6, Mch6) (accession number: U60521)
(forward; nt 274–293)58-AACAGGCAAGCAGCAAAGTT-38
(reverse; nt 765–784)58-TCCATCTGTGCCGTAGACAG-38
caspase-10 (Mch4) (accession number: U60519)
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(forward; nt 209–228)58-TGCTGAGTGAGGAAGACCCT-38
(reverse; nt 722–741)58-CCTCTGTGGTTCCGATTCAT-38
fas (accession number: M67454)
(forward; nt 373–392)58-ATAAGCCCTGTCCTCCAGGT-38
(reverse; nt 1023–1042)58-TGATGCCAATTACGAAGCAG-38
fasL (accession number: D38122)
(forward; nt 647–666)58-CAACTCAAGGTCCATGCCTC-38
(reverse; nt 984–1004)58-AGATTCCTCAAAATTGACCAG-38
Primers were designed using the PCgene program for DNA analysis from
Intelligenetics (Mountain View, CA) and the Primer3 program (S. Roze and H.
J. Skaletsky, Whitehead Institute for Biomedical Research, MIT Center for
Genome Research, Boston, MA). The conditions for PCR amplification of
cDNA were as follows: one cycle at 95°C for 5 min as an initial denaturation
step; then, denaturation at 95°C for 30 s, annealing for 30 s, and extension at
72°C for 90 s (the number of cycles was 26 to 30, depending on the linear
range); followed by further incubation for 15 min at 72°C (one cycle). The
annealing step was carried out at 60°C (bcl-w, caspase-1, caspase-5, caspase-
6); 64°C (caspase-3), 65°C (bik, caspase-6, fas), 66°C (bfl-1), 67°C (caspase-7),
or 69°C (bax, bak, bcl-xL, bad, caspase-2, caspase-4, caspase-8, caspase-9,
caspase-10, and fasL). These experimental conditions were shown to be at the
linear phase of amplification for each gene. In some cases, we performed PCR
reactions using a higher number of cycles in order to assess the expression of a
specific gene as indicated in the respective figure legend. After amplification,
an aliquot of the PCR reaction was size fractionated onto a 2% agarose gel in
13 TAE (40 mM Tris-acetate, 1 mM EDTA, pH 8.0) and checked for the
expected PCR products. Using the above-described primers, the expected sizes
of PCR products for each gene were as follows: bcl-w (363 bp), bcl-2 (367 bp),
bax (366 bp), bik (251 bp), bfl-1 (504 bp), bak (1192 bp), bcl-xL (542 bp), bcl-xs
(353 bp), bad (316 bp), caspase-1 (1076 bp), caspase-2 (386 bp), caspase-3
(400 bp), caspase-4 (502 bp), caspase-5 (564 bp), caspase-6 (753 bp),
caspase-7 (537 bp), caspase-8 (558 bp), caspase-9 (511 bp), caspase-10 (533
bp), fas (670 bp), fasL (358 bp), b-actin (254 bp).
cDNA cloning and sequencing
The PCR products were directly cloned into the pCRy2.1 vector using the TA
cloning kit (InVitrogen, San Diego, CA) following the manufacturer’s indica-
tions. DNA sequencing was performed by thermal cycle sequencing with a
Cy5yAutoCycley sequencing kit (Pharmacia LKB Biotechnology) and by
automated laser fluorescent DNA sequencing (Pharmacia LKB Biotechnology)
as well as with a PE Applied Biosystems 377 DNA sequencer (Perkin Elmer,
Foster City, CA).
Western blot analysis
About 107 cells were pelleted by centrifugation, washed with PBS, and lysed
with 50 µL of a lysis buffer containing protease inhibitors (20 mM HEPES, pH
7.5, 10 mM EGTA, 40 mM b-glycerophosphate, 1% NP-40, 2.5 mM MgCl2, 2
mM orthovanadate, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 20 µg/mL
aprotinin, 20 µg/mL leupeptin). After 20 min on ice, solubilized proteins were
obtained by centrifugation, boiled in Laemmli sample buffer (2% SDS, 10%
glycerol, 140 mM b-mercaptoethanol, 60 mM Tris-HCl, pH 6.8, 0.01%
bromophenol blue), and electrophoresed in SDS-polyacrylamide gels. Protein
was measured with a Bio-Rad Protein Assay kit. Proteins (20 µg) were
separated through 12% SDS-polyacrylamide gels under reducing conditions,
transferred to nitrocellulose filters, and subjected to immunological detection.
Pre-stained protein molecular mass standards (Bio-Rad) were also run in the
same gel. After electrophoresis and blocking for 1 h in 3% powdered defatted
milk in TBS buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl), the nitrocellulose
filters were incubated overnight with the respective specific antibodies
(dilution 1:1000 in TBS buffer containing 0.05% Tween 20): mouse monoclonal
anti-caspase-2 antibody, rabbit polyclonal anti-caspase-3 antibody, and rabbit
polyclonal anti-caspase-10 antibody. Filters were then incubated for 1 h with
biotinylated anti-mouse IgG or anti-rabbit IgG (both diluted at 1:1000 in TBS
buffer containing 0.05% Tween 20), followed by streptavidin-horseradish
peroxidase conjugate (diluted 1:1000 in TBS buffer containing 0.05% Tween
20). Signals were developed using an enhanced chemiluminescence detection
(ECL) system (Amersham, Buckinghamshire, UK).
RESULTS
Spontaneous apoptosis in human neutrophils
and during neutrophil differentiation
of HL-60 cells
Human neutrophils, isolated from peripheral blood, were
immediately incubated at 37°C in RPMI 1640 culture medium
containing 10% (v/v) heat-inactivated fetal calf serum for 0, 5,
9, 12, and 24 h in a humidified atmosphere of air/CO2 (19/1). At
these incubation times, cells were collected and analyzed for
internucleosomal DNA degradation, a hallmark of apoptosis.
As shown in Figure 1, human neutrophils started to undergo
apoptosis after 9–12 h incubation, increasing this apoptotic
response with the incubation time. This time course of neutro-
phil spontaneous apoptosis is in agreement with previous
reports [2, 4, 5, 30]. Figure 2 shows the distinct morphological
stages of the human neutrophil apoptotic process upon incuba-
tion in complete culture medium as above. After 3-h incuba-
tion, a small vacuolation could be detected in the neutrophil
cytoplasm (Fig. 2B). After 9 h of incubation, numerous
cytoplasmic vacuoles and initial chromatin condensation were
observed (Fig. 2C). Then, after 15 h of incubation, chromatin
condensation is highly increased. Rounded or oval masses of
dense chromatin are attached to each other by a single slender
chromatin filament and some nuclei adopt a four-leaf clover
appearance (Fig. 2D). At this stage, some cells are devoid of
nucleus and show large cytoplasmic vacuoles (Fig. 2D). After
24 h of incubation, the proportion of apoptotic neutrophils
devoid of nucleus and exhibiting large vacuoles was highly
increased, whereas other neutrophils displayed highly con-
densed chromatin masses bound by fine chromatin filaments
(Fig. 2E). Apoptotic neutrophils became rounded and showed a
very smooth surface.
It has been previously reported that the human promyelo-
cytic HL-60 cell line induced to differentiate toward neutro-
phils subsequently die by apoptosis [28, 29, 40]. In this regard,
we have found that induction of HL-60 cell differentiation
toward neutrophils by treatment with 1.3% (v/v) DMSO is
accompanied by the appearance of DNA internucleosomal
degradation (Fig. 3A). HL-60 cells started to undergo apopto-
sis after 4 days of DMSO treatment (Fig. 3A), in agreement with
previous estimates [28]. Undifferentiated HL-60 cells are
proliferative CD71-positive and CD11b-negative cells that are
unable to generate superoxide anion, and thereby to reduce
NBT, whereas mature peripheral blood neutrophils are terminal
Fig. 1. Time course of spontaneous apoptosis in
human peripheral blood neutrophils. Freshly isolated
human neutrophils were incubated in RPMI 1640
culture medium containing 10% fetal calf serum for
the indicated times, and then DNA fragmentation was
assayed as described in Materials and Methods.
Fragmented DNA from 8 3 105 cells was loaded in
each lane. The experiment shown is representative of
four performed.
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non-proliferative CD71-negative and CD11b-positive cells with
a high capacity to reduce NBT [28, 49]. We have used these
parameters to monitor the differentiation process of HL-60 cells
during DMSO treatment. As shown in Figure 3 and Figure 4,
we found that the initiation of apoptosis in DMSO-induced
neutrophil differentiation of HL-60 cells (after a 4-day DMSO
incubation) correlated with the acquisition of most of the
neutrophil functional and biochemical features by the DMSO-
treated HL-60 cells [28].
Bcl-2 overexpression prevents apoptosis, but not
differentiation, of DMSO-treated HL-60 cells
It has been previously shown that differentiation and apoptosis
can be uncoupled by overexpression of bcl-2 [41, 50, 51]. In
agreement with these reports, we have found that overexpres-
sion of bcl-2 by gene transfer prevented apoptosis triggered
during neutrophil differentiation (Fig. 3B), but it did not block
the differentiation process induced by DMSO (Fig. 4). We found
that Bcl-2-transfected HL-60 cells, which expressed a fivefold
increase in the endogenous level of Bcl-2 protein [41], under-
went even a more rapid and potent differentiation process
toward cells sharing many features of neutrophils than control
HL-60-Neo cells, as assessed by the cell surface expression of
the CD11b leukocyte antigen (Fig. 4A) and the respiratory burst
activity, measured by NBT reduction (Fig. 4C). In contrast, the
inhibition of the proliferative capacity of HL-60 cells and the
concomitant internalization of the cell-surface transferrin recep-
tor (CD71 antigen) were somewhat slowed down in Bcl-2-
transfected HL-60 cells (Fig. 4, B and D). Untransfected HL-60
cells showed a similar pattern of differentiation to that of
HL-60-Neo cells (data not shown). These results indicate that
Bcl-2-transfected HL-60 cells acquire several neutrophil fea-
tures before cessation of proliferation during DMSO-induced
neutrophil differentiation.
mRNA expression of bcl-2 family genes in
human neutrophils and during neutrophil
differentiation of HL-60 cells
Apoptosis is controlled by a number of ‘‘pro-suicide’’ (bax,
bcl-xs, bak, bik, bad) and ‘‘anti-suicide’’ (bcl-2, bcl-xL, bfl-1/A1,
bcl-w) genes that are members of the bcl-2-related gene family
Fig. 2. Morphological changes during spontaneous apoptosis in human
peripheral blood neutrophils. Freshly isolated human neutrophils were incu-
bated at 37°C in RPMI 1640 culture medium containing 10% fetal calf serum
for 0 (A), 3 (B), 9 (C), 15 (D), and 24 (E) h. May-Gru¨nwald-Giemsa-stained
preparations were photographed. The experiment shown is representative of
four performed.
Fig. 3. Inhibition of neutrophil differentiation-induced apoptosis in HL-60
cells by overexpression of Bcl-2. Time course of induction of apoptosis in
HL-60-Neo cells (A) and HL-60-Bcl-2 cells (B) treated with 1.3% (v/v) DMSO
for the indicated times. Analysis of DNA fragmentation was performed as
described in Materials and Methods. Control untreated HL-60 cells were also
run. A 123-bp DNA ladder, used as standard, is shown (STD). Fragmented
DNA from 8 3 105 cells was loaded in each lane. Experiments shown are
representative of three performed.
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[19–22]. Previous reports have indicated that neutrophils lack
bcl-2 expression [36, 39], and this could be related to their
readiness to undergo spontaneous apoptosis. However, due to
the redundancy in the biological actions of the bcl-2 family
members, we have studied the expression of a wide panel of
bcl-2 family genes in both human neutrophils and neutrophil-
differentiating HL-60 cells through semiquantitative RT-PCR.
We investigated whether the spontaneous apoptosis displayed
by HL-60 neutrophils and mature peripheral blood neutrophils
might reflect a characteristic and differential expression of
survival and death-promoting genes. Undifferentiated HL-60
expressed bak, bik, bax, bad, bcl-2, bcl-xL, bcl-w, and bfl-1/A1
(Fig. 5), assessed by subsequent cloning and sequencing. The
nucleotide sequence of human bfl-1 [52] was 100% identical to
that of human A1 [53]. Thus, we have used the term bfl-1/A1 or
bfl-1, interchangeably, throughout this work to refer to this
human gene. As shown in Figure 5A, differentiation of HL-60
cells toward neutrophils with DMSO resulted in changes in the
expression of some bcl-2 family genes: (1) bcl-2 and bik were
rapidly down-regulated; (2) bak, bcl-w, and bfl-1/A1 were
up-regulated; (3) bax, bad, and bcl-xL remained unchanged.
Bcl-x is expressed in two distinct mRNA species by alternative
splicing. The longer cDNA, bcl-xL, encodes a 233-amino-acid
protein inhibiting cell death, and the shorter cDNA, bcl-xs,
contains a deletion of 189 nt (63 amino acids) from the bcl-xL
open reading frame and encodes a 170-amino-acid protein that
promotes apoptosis [54]. The primers used in this study for
bcl-x expression were designed to amplify both the bcl-xL and
the bcl-xs isoforms, giving the expected PCR-amplified frag-
ments of 542 and 353 bp for bcl-xL and bcl-xs, respectively.
Expression of bcl-xs in HL-60 cells was only detected after
increasing the number of cycles (up to 40 cycles), although its
expression level was much lower than that of bcl-xL (Fig. 5B). It
is interesting to note, we found that the pattern of expression of
Fig. 4. Analysis of neutrophil differentiation in HL-60-Neo and HL-60-Bcl-2
cells induced by DMSO. HL-60-Neo (filled circles) and HL-60-Bcl-2 (open
circles) cells were treated with 1.3% (v/v) DMSO for the times indicated and
different markers to monitor neutrophil differentiation were examined as
described in Materials and Methods. These differentiation markers include
CD11b and CD71 cell-surface expression (A and B), capacity to generate
superoxide anion assessed by NBT reduction (C), and cell proliferation (D).
Data shown are representative of one experiment out of three performed.
Fig. 5. Expression of bcl-2 gene family members in neutrophil differentiation
of HL-60 cells, human peripheral blood neutrophils and NB4 cells. (A) The
pattern of expression of the indicated bcl-2 family members during DMSO-
induced neutrophil differentiation of HL-60 cells was assessed by semiquanti-
tative RT-PCR analysis. Total RNA was purified from untreated HL-60 cells as
well as from HL-60 cells treated with 1.3% (v/v) DMSO for the indicated times,
and subjected to semiquantitative RT-PCR analysis with oligonucleotide
primers specific for each gene. PCR amplification of b-actin was used as an
internal control. After 26 cycles (bak, bax, bfl-1) and 28 cycles (bik, bad, bcl-2,
bcl-xL, bcl-w), shown to be at the linear phase of amplification, the PCR
products were electrophoresed onto a 2% agarose gel and stained with ethidium
bromide. (B) The pattern of expression of the indicated bcl-2 family members in
human peripheral blood polymorphonuclear neutrophils (PMN), human acute
myeloid leukemia HL-60 cells, and promyelocytic NB4 cells was assessed by
RT-PCR analysis. bad and bcl-w were not analyzed in NB4 cells. Arrowheads
indicate the predicted PCR products for bcl-xL (top arrowhead) and bcl-xs
(bottom arrowhead). Total RNA was purified from these cells and subjected to
RT-PCR analysis with oligonucleotide primers specific for each gene. PCR
amplification of b-actin was used as an internal control. After 26 cycles (bfl-1),
27 cycles (bak), 28 cycles (bik, bax, bcl-2, bcl-w), 30 cycles (bad), and 40 cycles
(bcl-xL), the PCR products were electrophoresed onto a 2% agarose gel and
stained with ethidium bromide. Experiments shown are representative of three
performed.
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bcl-2 family genes in human mature peripheral blood neutro-
phils was very similar to that shown by HL-60 cells differenti-
ated toward neutrophils after a 4-day DMSO treatment, with the
exception of bax and bcl-xL (Fig. 5). We have compared the
relative level of expression of bcl-2 family members between
human neutrophils and other human myeloid cell lines, such as
undifferentiated acute myeloid leukemia HL-60 cells [29, 40,
28] and promyelocytic NB4 cells [55]. Human neutrophils did
not express bik, bax, bcl-2, bcl-xL, and bcl-xs, but did express
significant levels of bak, bad, bcl-w, and bfl-1, as assessed by
RT-PCR and subsequent cloning and sequencing. It is worth
noting the remarkably high expression of bfl-1/A1 in neutro-
phils when compared to other human myeloid cell lines. This
characteristic high level of bfl-1 expression in human neutro-
phils correlated well with the potent induction of this gene
during HL-60 neutrophil differentiation (Fig. 5). bak was also
abundantly expressed in peripheral blood neutrophils and
correlated with its induction during HL-60 neutrophil differ-
entiation (Fig. 5). A quantitative analysis of the changes
detected in the expression of the above bcl-2 family members
during neutrophil differentiation of HL-60 cells is shown in
Figure 6. The levels of mRNA of bfl-1, bcl-w, and bak were
increased about 6.5-, 3.3- and 3.1-fold, respectively, after a
4-day DMSO treatment, whereas those of bcl-2 and bik were
drastically reduced (Fig. 6). The levels of bcl-xL, bad, and bax
transcripts were slightly reduced during the DMSO treatment
(Fig. 6).
Participation of caspases in
differentiation-induced HL-60 apoptosis
and in spontaneous peripheral blood
neutrophil cell death
An increasing number of cysteine proteases that specifically
cleave proteins after Asp residues, named caspases, are
absolutely required for the accurate and limited proteolytic
events that typify programmed cell death [23, 24]. Thus, it is
reasonable to think that caspase activation must play a role in
the apoptotic process that follows the HL-60 neutrophil differ-
entiation process. As shown in Figure 7, treatment of HL-60
cells with the caspase inhibitor z-Asp-2,6-dichlorobenzoyloxy-
methylketone prevented the induction of apoptosis during
HL-60 neutrophil differentiation, but did not affect the differen-
tiation process of these cells, as assessed by the cell-surface
expression of CD11b, a marker of myeloid differentiation [28].
As nonproliferating cells, freshly isolated peripheral blood
human neutrophils were arrested in G1/G0 cell cycle phase, but
the appearance of cells with a DNA content less than G1/G0
(hypodiploidy), characteristic of apoptotic cells, was observed
upon incubation in serum-containing culture medium (Fig. 8).
Incubation of peripheral blood mature neutrophils with z-Asp-
2,6-dichlorobenzoyloxymethylketone blocked neutrophil spon-
taneous apoptosis, as assessed by flow cytometry (hypodiploidy)
and morphological analysis (Fig. 8). Thus, internucleosomal DNA
degradation and the typical morphological features of apoptotic
neutrophils were prevented by caspase inhibition (Fig. 8).
mRNA expression of caspases in human
neutrophils and during neutrophil
differentiation of HL-60 cells
We found that undifferentiated HL-60 cells expressed caspase-1
(ICE), caspase-2 (ICH-1), caspase-3 (CPP32, Yama, apopain),
caspase-4 (ICErelII, TX, ICH-2), caspase-7 (Mch3, ICE-LAP3,
CMH-1), caspase-8 (MACHalpha, FLICE, Mch5), caspase-9
(ICE-LAP6, Mch6), and caspase-10 (Mch4, FLICE-2) (Fig. 9),
as assessed by subsequent cloning and sequencing. In the case
of caspase-1, we found that the nucleotide sequence corre-
sponded to the ICEb isoform [56]. Caspase-2 (ICH-1) is
alternatively spliced into two distinct Ich-1 mRNA species that
encode proteins with opposite effects on cell death [57]. One
mRNA species encodes a protein product of 435 amino acids
(ICH-1L), which acts as an inducer of programmed cell death,
whereas the other mRNA species encodes a 312-amino-acid
truncated version of ICH-1L protein, named ICH-1s, that acts as
a negative regulator of apoptosis [57]. The primers used in this
study for caspase-2 (ICH-1) expression were chosen to amplify
both forms, giving expected sizes of 345 for Ich-1L and 406 bp
for Ich-1s; the size of the amplified fragment for Ich-1s being
higher due to the insertion of 61 nt in its mRNA sequence,
which leads to a truncated version of ICH-1L protein. As shown
in Figure 9, HL-60 cells mainly expressed the Ich-1L isoform
(caspase-2), and the Ich-1s isoform was only detected when the
number of cycles used in the PCR reaction was increased (Fig.
9B). We were unable to detect expression of caspase-5
(ICErelIII, TY) and caspase-6 (Mch2) under semiquantitative
RT-PCR conditions, using 20–25 cycles. Expression of caspase-5
Fig. 6. Relative changes in the induction of bcl-2 gene family members during
neutrophil differentiation of HL-60 cells. Values represent fold induction in the
mRNA level of the indicated anti-apoptotic (A) and pro-apoptotic (B) bcl-2
family members during DMSO-induced neutrophil differentiation of HL-60
cells. In semiquantitative RT-PCR experiments similar to that shown in Fig. 5,
the corresponding amplified band of each bcl-2 family gene was quantified by
densitometric scanning. Each value was corrected for the amplified b-actin
band, and the fold induction was calculated by comparison with the correspond-
ing value in untreated control cells. Data are shown as mean values 6 SE of
three independent experiments.
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and caspase-6 in HL-60 cells were only detected after two
consecutive PCR reactions, where the first PCR product was
used as a template DNA in the second PCR reaction (data not
shown), indicating that these two caspases were expressed at
very reduced levels in these cells. Differentiation of HL-60
cells toward neutrophils with DMSO resulted in changes in the
pattern of caspase expression. Caspases 1 and 9 were up-
regulated; caspases 2, 3, and 10 were down-regulated; and the
levels of expression of caspases 4, 7, and 8 were essentially
unmodified during DMSO treatment (Fig. 9A). We found by
RT-PCR, and subsequent cloning and sequencing, that mature
neutrophils expressed high levels of caspases 1, 4, 7, 8, and 9,
and lower levels of caspases 3 and 10, whereas caspase-2 was
essentially absent (Fig. 9B). Like HL-60 cells, mature neutro-
phils hardly expressed caspase-5 and caspase-6, and a second
consecutive PCR reaction, using the first PCR product as
template DNA for the second PCR round, was required to
detect their expression.
Changes in the level of mRNA expression
of bcl-2 and caspase family genes during
prolonged treatment of HL-60 cells with DMSO
It has been classically considered that complete differentiation
of HL-60 cells toward neutrophils occurred after a 7-day DMSO
treatment. The apoptotic gene expression changes detected after
the 4-day DMSO treatment of HL-60 cells (Figs. 5 and 9) were
also observed after prolonged incubation times of HL-60 cells
with DMSO. Thus, bik, bcl-2, caspase-2, caspase-3, and caspase-10
were down-regulated; bfl-1/A1, caspase-1, and caspase-9 were
up-regulated; and expression of bax, bad, bcl-xL, caspase-4,
caspase-7, and caspase-8 was essentially unmodified (Fig.
10). However, some peculiarities were observed during pro-
longed incubation of HL-60 cells with DMSO. Expression of
bak and bcl-w were up-regulated during the first 4 days of
DMSO treatment (Figs. 5 and 10), but then their expression was
down-regulated (Fig. 10A). Overall, these data further support
the notion that a 4-day DMSO treatment leads to a differentia-
tion stage of HL-60 cells that shares many functional, biochemi-
cal, and gene expression features with mature neutrophils.
Fas and FasL mRNA expression in human
neutrophils and during neutrophil differentiation of
HL-60 cells
The Fas/FasL system plays a major role in the initiation of the
apoptotic response. We found that undifferentiated HL-60 cells
Fig. 7. Caspase inhibition prevents apoptosis during neutro-
phil differentiation of HL-60 cells. HL-60 cells were incu-
bated with 1.3% (v/v) DMSO in the absence (2 in A; solid
histogram in B) or in the presence (1 in A; open histogram in
B) of 50 µM z-Asp-2,6-dichlorobenzoyloxymethylketone for
the indicated times in RPMI 1640 culture medium containing
10% fetal calf serum as described in Materials and Methods.
Control untreated cells were also run. Cells were then analyzed
for internucleosomal DNA degradation (A) and CD11b cell-
surface expression (B), as markers for apoptosis and myeloid
differentiation. Fragmented DNA from 8 3 105 cells was
loaded in each lane of panel A. (A) Experiment shown is
representative of four performed. (B) Data are mean values 6
SE of three independent determinations.
Fig. 8. Caspase inhibition prevents spontaneous neutrophil apoptosis. Freshly
isolated peripheral blood human neutrophils were immediately processed for
flow cytometry (A) and morphological staining (B) as below, or incubated at
37°C in RPMI 1640 culture medium containing 10% fetal calf serum for 24 h in
the absence and in the presence of z-Asp-2,6-dichlorobenzoyloxymethylketone
(z-D-dbmk). Neutrophils were then stained with propidium iodide, and their
DNA content analyzed by fluorescence flow cytometry (A), as described in
Materials and Methods. The positions of the G1/G0 cell cycle phase (arrow) and the
sub-G1/G0 peak (*), integrated by apoptotic cells, are indicated. Neutrophils were also
May-Gru¨nwald-Giemsa-stained (B) to examine the morphological apoptotic features.
Experiments shown are representative of three performed.
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expressed fas, and its expression was largely increased during
neutrophil differentiation (Fig. 11). The level of expression of
fas was very high in mature neutrophils and HL-60 neutrophils,
cells committed to undergo spontaneous and rapid cell death,
when compared to untreated HL-60 cells (Fig. 11). FasL was
also expressed, but at very low levels, in human neutrophils and
in undifferentiated HL-60 cells; its level of expression being
unmodified during the neutrophil differentiation process of
HL-60 cells (Fig. 11).
Caspase protein expression in human
neutrophils and during neutrophil
differentiation of HL-60 cells
Because caspases 2, 3, and 10 were down-regulated at the
mRNA level during neutrophil differentiation of HL-60 cells
(Figs. 9 and 10), we analyzed whether these changes were
reflected at the protein level. Caspase-3 and -10 protein levels,
detected as 36- and 55-kDa bands, respectively, were de-
creased during HL-60 cell differentiation until achieving the
corresponding protein levels found in peripheral blood neutro-
phils (Fig. 12). The 48-kDa caspase-2 protein content was
dramatically reduced after DMSO treatment of HL-60 cells,
and was not detected in both HL-60-differentiated neutrophils
and peripheral blood neutrophils (Fig. 12). The above de-
creases in caspase protein content were not due to the
proteolytic cleavage of caspases occurring during apoptosis
because these changes were observed before the induction of
apoptosis, triggered after a 4-day DMSO treatment. These
results show a correlation between changes in both mRNA and
protein levels of caspases during neutrophil differentiation.
Fig. 9. Expression of caspases in neutrophil differentiation of HL-60 cells,
human peripheral blood neutrophils, and NB4 cells. (A) The pattern of
expression of the indicated caspases during DMSO-induced neutrophil differen-
tiation of HL-60 cells was assessed by semiquantitative RT-PCR analysis. Total
RNA was purified from untreated HL-60 cells as well as from HL-60 cells
treated with 1.3% (v/v) DMSO for the indicated times, and subjected to
semiquantitative RT-PCR analysis with oligonucleotide primers specific for
each gene. PCR amplification of b-actin was used as an internal control. After
24 (caspase-4), 25 (caspase-1, caspase-9, caspase-10), 26 (caspase-2, caspase-3,
caspase-7), and 27 cycles (caspase-8), shown to be at the linear phase of
amplification, the PCR products were electrophoresed onto a 2% agarose gel
and stained with ethidium bromide. (B) The pattern of expression of the
indicated caspases in human peripheral blood PMN, human acute myeloid
leukemia HL-60 cells, and human promyelocytic NB4 cells was assessed by
RT-PCR analysis. Arrowheads indicate predicted PCR products for both
isoforms of caspase-2, namely Ich-1L (bottom arrowhead) and Ich-1s (top
arrowhead). Total RNA was purified from these cells and subjected to RT-PCR
analysis with oligonucleotide primers specific for each gene. PCR amplification
of b-actin was used as an internal control. After 25 (caspase-4), 27 (caspase-1,
caspase-9, caspase-10), 28 (caspase-3, caspase-7, caspase-8), and 35 cycles
(caspase-2), the PCR products were electrophoresed onto a 2% agarose gel and
stained with ethidium bromide. Experiments shown are representative of three
performed.
Fig. 10. Expression of members of the bcl-2 and caspase gene families during
prolonged incubations of HL-60 cells with DMSO. The pattern of expression of
the indicated bcl-2 and caspase family members during DMSO-induced
neutrophil differentiation of HL-60 cells was assessed by semiquantitative
RT-PCR analysis. Total RNA was purified from untreated HL-60 cells as well
as from HL-60 cells treated with 1.3% (v/v) DMSO for the indicated times, and
subjected to semiquantitative RT-PCR analysis with oligonucleotide primers
specific for each gene. PCR amplification of b-actin was used as an internal
control. The number of cycles used for each gene were the same as those
previously described in Figs. 5 and 9, shown to be at the linear phase of
amplification. The PCR products were electrophoresed onto a 2% agarose gel
and stained with ethidium bromide. Experiments shown are representative of
three performed.
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DISCUSSION
The results reported here indicate that the onset of apoptosis in
neutrophil-differentiating HL-60 cells is correlated with the
achievement of an apoptosis-related gene expression pattern
similar to that constitutively expressed in mature neutrophils.
Thus, HL-60 cells are a useful cell culture model to study
molecular aspects of the human neutrophil spontaneous apopto-
sis. Figure 13 summarizes the results herein reported concern-
ing the mRNA expression pattern of a wide number of
apoptosis-related genes in human peripheral blood mature
neutrophils as well as during neutrophil differentiation of the
HL-60 cell line. HL-60 cells treated with DMSO for 4 days
acquire most of the biochemical and functional characteristics
of mature neutrophils, including their capacity to undergo
spontaneous apoptosis, and show an apoptotic gene expression
pattern very similar to that found in mature neutrophils. This
suggests that the changes observed in the expression levels of
several apoptosis-related genes during neutrophil differentia-
tion of HL-60 cells can play a role in the acquisition of their
capacity to undergo spontaneous apoptosis. Expression of
mRNA bcl-2 in HL-60 cells was dramatically inhibited during
the first 24-h DMSO treatment, time required to induce
irreversibly HL-60 cells to differentiate toward neutrophils
[58]. It is interesting that bfl-1/A1 expression was highly
up-regulated during neutrophil differentiation of HL-60 cells.
This is in agreement with a previous report showing an
elevation of A1 mRNA level during neutrophil differentiation of
the murine 32D cl3 cell line with G-CSF [59]. We have found
that human peripheral blood neutrophils and HL-60 neutro-
phils, which undergo spontaneous apoptosis, are prominent in
bfl-1/A1 expression, an antiapoptotic gene. The expression of
apoptosis-accelerating genes, such as bax and bak, is wide-
spread in different tissues [60, 61], whereas the expression of
apoptosis-blocking genes, such as bcl-xL and bfl-1/A1, is
restricted in some tissues [52–54], suggesting that the activity
of proapoptotic genes may be regulated by death inhibitory
genes. The present results indicate that human neutrophils
express two anti-apoptotic genes, bfl-1/A1 and bcl-w, which
may have an important role in the maintenance of the lifespan
of neutrophils. bfl-1/A1 is the only known bcl-2 family member
that is inducible by inflammatory cytokines [53]. Thus, it is
tempting to speculate that the high expression of bfl-1/A1 found
in human neutrophils could be related to a protective role in
these cells during the inflammatory response. bfl-1/A1 mRNA
has been reported to be up-regulated by agonists (G-CSF, LPS)
that promote neutrophil survival [62]. Bfl-1/A1 is able to
interact with Bax, Bak, and Bcl-2 [63]. We have found that
mature neutrophils and neutrophil-differentiated HL-60 cells
express high levels of bfl-1/A1 and bak, and lower levels of bad
and bcl-w. It can be suggested that bfl-1/A1 and bak play a
major role in regulating apoptosis in mature neutrophils
because: (1) both genes are the bcl-2 family members most
abundantly expressed in mature neutrophils; (2) they are
strongly up-regulated during HL-60 neutrophil differentiation;
and (3) both genes can form homodimers and heterodimers
regulating the cell fate.
The importance of bcl-2 family genes in the differentiation-
induced apoptosis in HL-60 cells is evidenced by the fact that
overexpression of bcl-2 or bfl-1/A1 prevents apoptosis during
myeloid differentiation [41, 50, 51, 64, this report]. We have
found that bcl-2 overexpression accelerates DMSO-induced
differentiation of HL-60 cells toward the neutrophil lineage;
whereas it prevents completely differentiation-induced apopto-
sis. IL-3 withdrawal from bcl-2-transfected FDCP Mix cells has
been reported to lead to differentiation, largely to neutrophils
[65]. We have also found that the DMSO-induced inhibition of
proliferation as well as the loss of CD71 antigen proceed
sluggishly in Bcl-2-transfected HL-60 cells compared with
Fig. 12. Caspase-2, -3, and -10 protein levels in neutrophil differentiation of
HL-60 cells and human peripheral blood neutrophils. Human peripheral blood
PMN, untreated HL-60 cells, and HL-60 cells treated with 1.3% (v/v) DMSO
for the indicated times were lysed, subjected to SDS-PAGE, and immunoblotted
with the respective antibodies as described in Materials and Methods. The
migration positions of full-length caspase-2, -3, and -10 are indicated. The
molecular masses (kDa) of protein markers are indicated on the left. Data shown
are representative of three experiments performed.
Fig. 11. Expression of fas and fasL in neutrophil differentiation of HL-60 cells
and human peripheral blood neutrophils. (A) The pattern of expression of fas
and fasL during DMSO-induced neutrophil differentiation of HL-60 cells was
assessed by semiquantitative RT-PCR analysis. Total RNA was purified from
untreated HL-60 cells as well as from HL-60 cells treated with 1.3% (v/v)
DMSO for the indicated times, and subjected to semiquantitative RT-PCR
analysis with oligonucleotide primers specific for each gene. PCR amplification
of b-actin was used as an internal control. After 28 cycles (fas), shown to be at
the linear phase of amplification, and 40 cycles (fasL), the PCR products were
electrophoresed onto a 2% agarose gel and stained with ethidium bromide. (B)
The pattern of expression of fas and fasL in human peripheral blood PMN and
human promyelocytic HL-60 cells was assessed by RT-PCR analysis. Total
RNA was purified from these cells and subjected to RT-PCR analysis with
oligonucleotide primers specific for each gene. PCR amplification of b-actin
was used as an internal control. After 27 (fas) and 40 cycles (fasL), the PCR
products were electrophoresed onto a 2% agarose gel and stained with ethidium
bromide. Experiments shown are representative of three performed.
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HL-60-Neo or untransfected HL-60 cells. In this regard, it has
been reported that bcl-2-transfected cells may temporarily
proliferate after growth factor removal [64, 66], suggesting a
link between Bcl-2 and cell cycle.
Involvement of caspase activation in neutrophil spontaneous
apoptosis was evidenced by prevention of apoptosis in differen-
tiating HL-60 cells and human peripheral blood neutrophils by
the aspartate-based caspase inhibitor z-Asp-2,6-dichloroben-
zoyloxymethylketone. Caspase expression patterns were well
correlated between human neutrophils and HL-60 neutrophils.
Caspase-3 and caspase-10 were down-regulated, both at mRNA
and protein levels, during neutrophil HL-60 differentiation,
until achieving the expression level of mature neutrophils.
Caspase-2 was drastically down-regulated, both at mRNA and
protein levels, during neutrophil differentiation, and was absent
in peripheral blood neutrophils and HL-60 differentiated
neutrophils. These results show a good correlation between
mRNA and protein expression levels and suggests that caspase-2
does not play any role in neutrophil spontaneous apoptosis.
The present results indicate that human peripheral blood
neutrophils express a characteristic pattern of apoptosis-related
genes, which includes: initiation genes (fas and fasL), pro-
apoptotic regulatory genes (bak and bad), anti-apoptotic regula-
tory genes (bfl-1/A1 and bcl-w), and executioner genes (caspases
1, 3, 4, 7, 8, 9, and 10). Thus, human neutrophils contain the
complete machinery necessary to regulate their own pro-
grammed cell death. The Fas/FasL system has been reported to
be of critical importance in the induction of mature neutrophil
apoptosis [36–38]. Binding of FasL to Fas induces trimerization
of Fas receptor that recruits caspase-8 via the FADD/MORT1
adaptor [67], forming the death-inducing signaling complex
(DISC). Recruitment of caspase-8 to the DISC leads to its
proteolytic activation, which initiates a cascade of caspases,
leading to apoptosis. HL-60 cells are resistant to Fas-mediated
apoptosis [68, 69], whereas mature neutrophils and neutrophil-
differentiated HL-60 cells rapidly undergo apoptosis upon Fas
activation [36–38, 40, 70]. This could be explained, in part, by
the increase in fas expression during neutrophil differentiation
of HL-60 cells and by the prominent expression of this gene in
peripheral blood neutrophils reported here. On the other hand,
it is interesting to note that human neutrophils express very
high levels of c-jun mRNA [71], a proto-oncogene involved in
programmed cell death [72, 73]. Thus, human neutrophils show
a wide expression pattern of genes involved in programmed cell
death. We suggest that this expression pattern of apoptosis-
related genes in human neutrophils, distinct from other cell
types, might be responsible for their peculiar spontaneous
apoptosis. Neutrophil apoptosis showed two characteristic
morphological features, namely: (1) rounded or oval masses of
condensed chromatin attached to each other by slender chroma-
tin filaments; (2) loss of nuclei and presence of large cytoplas-
mic vacuoles instead. Internucleosomal DNA fragmentation
occurred after 9–12 h of incubation of mature neutrophils in
serum-containing culture medium.
Apoptosis is mainly regulated by the ratio of cell death
promoters/inhibitors, which will ultimately dictate the final
outcome. As shown here, the expression pattern and the
balance of apoptosis-related genes are very similar in both
undifferentiated proliferating HL-60 and NB4 human leukemic
cells, but differ from the gene expression pattern observed in
terminal myeloid cells ready to undergo apoptosis (mature
neutrophils and HL-60 neutrophils). It could be envisaged that
some changes in gene expression can be of major importance to
render HL-60 cells susceptible to undergoing apoptosis during
DMSO-induced neutrophil differentiation, namely the down-
regulation of the anti-apoptotic bcl-2, and the up-regulation of
fas and bak, which initiate and promote, respectively, pro-
grammed cell death. The results reported here suggest that the
similar pattern of expression of survival and death-promoting
genes shown in this study in both HL-60 neutrophils and
peripheral blood mature neutrophils might lead to the character-
istic and spontaneous apoptosis exhibited by these cell types.
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